On the market it was said that there was a lack of new tangible impulses to justify a further increase. At the beginning, the US stock exchanges would have understood the strength of the world stock exchanges on Monday when US trading paused on “George Washington Day”. Progressive vaccination campaigns and falling numbers of new infections are good for the economic perspective in the midst of the corona pandemic, but have long been mentioned as drivers, it said. This was underpinned on Tuesday by the Empire State Index for February, which was twice as high as expected.
Other indices mimicked the Dow and also hit record highs in early trading on Tuesday before the momentum subsided. The S&P 500 was last unchanged in percentage terms at 3934.99 points. The technology-heavy Nasdaq 100, however, fell by 0.27 percent to 13,769.85 points.
On Tuesday, investors were once again focused on oil prices after the US WTI variety picked up on its most recent soaring. A barrel of the US WTI variety rose to around 60 US dollars, the highest level since the beginning of 2020. Oil stocks benefited from this: those of the industry giant ExxonMobil, for example, rose by 2.9 percent.
Otherwise, the industry was mainly interested in financial stocks, which was justified on the stock exchange with rising market interest rates. This can be seen from the recently rising bond yields. This is considered to be beneficial for the day-to-day business of financial institutions. In the Dow, JPMorgan stocks rose 2.7 percent and Goldman Sachs stocks rose 1.7 percent.
The falling number of infections and the progress made with the vaccination campaign let investors in the US travel sector have access again. The shares of the major airlines American Airlines, United and Delta rose by up to 2.9 percent. For those of the cruise lines Royal Caribbean and Carnival, it even went up by eight percent each.
In return, papers from the health sector were avoided. The shares of the corona vaccine manufacturers rowed back somewhat after a good run, as price losses of around three percent at Biontech and Moderna show. A fourth corona vaccine could come onto the market in Europe in mid-March, and Johnson & Johnson has now applied for approval there. However, the paper of the consumer goods and pharmaceutical company also fell by 0.9 percent.
The focus was otherwise on secondary stocks, including the 4.6 percent higher stake in the US auto supplier Borgwarner, which plans to take over the German battery manufacturer Akasol for almost 730 million euros.
The shares of Palantir Technologies lost 11.8 percent, however, after the specialist for data analysis software surprised negatively with an expansion of its losses in the past fourth quarter. For the first time since the IPO at the end of September, the shares, which had performed well to date, tested the 50-day average line. This is a popular trend indicator for chart-oriented investors.
In contrast, there was a price jump of nine percent for the Ceva share. The technology company surprised with adjusted earnings metrics that exceeded expectations./tih/he
(AWP)
–
